[#item_full_content] A bill signed into law by President Donald Trump last month banning fentanyl analogues would also make a series of changes to current laws that have restricted research into Schedule I drugs like marijuana and psychedelics, congressional analysts say. In a report published last week—shortly after Trump gave final approval to the Halt All Lethal 
Read More
